Hummingbird Diagnostics to Present Blood-Based RNA Biomarker Data in Stage III Lung Cancer at ESMO 2026
More Information HEIDELBERG, Germany, September 30, 2026 – Hummingbird Diagnostics GmbH, a molecular diagnostics company specializing in blood-based small RNA analysis for precision oncology, today announced that data from a new collaborative study will be presented at the ESMO Congress 2026 in Madrid, Spain. Building on Hummingbird’s expertise in early cancer detection, the study explores […]

